论文部分内容阅读
1979年作者报告了在8～10年前接受Cendehill 疫苗而无再感染证据的对象中,风疹血凝抑制(HI)和中和(SN)抗体滴度,嗣后Best 等指出,在作者使用的 RK13细胞中所
In 1979, the authors reported on rubella hemagglutination inhibition (HI) and neutralizing (SN) antibody titers in subjects who received Cendehill vaccine 8 to 10 years earlier without re-infection, and Best et al later indicated that the use of RK13 In the cell